Bloomberg Regeneron Pharmaceuticals Inc said it plans to cut some staff as it restructures its partnership with French drugmaker Sanofi, with whom it had shared drug sales responsibilities. Regeneron employees to be affected work on the rheumatoid arthritis drug Kevzara, which Sanofi is expected to gain global rights to under the restructuring. There will be no Kevzara roles at Regeneron ...

Bloomberg Melinta Therapeutics Inc, a bio-pharmaceutical company specialising in infectious disease treatment, filed for Chapter 11 bankruptcy in Delaware with plans to continue operating. Melinta listed as much as $500 million in assets and up to $500 million in liabilities in its bankruptcy petition. Founded in 2000 by scientists including Nobel Prize winner Thomas Steitz, the company sells drugs that ...

Bloomberg In the agriculture world, news of the partial US-China trade deal has sparked a lot of buzz about soybeans. It turns out, wheat could actually end up being a bigger surprise winner. Speculations is mounting that China will work to fill its wheat-buying quota as part of the detente, a pledge it failed to stick to in the past. ...